Cargando…

Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center

BACKGROUND: Several patients with ulcerative colitis (UC) suffer from psychiatric disorders, such as major depressive disorder, anxiety, or bipolar disorder, and show specific personality traits. Despite this, there are few data about personality profiles’ characterization in UC patients and about c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scaldaferri, Franco, D’Onofrio, Antonio Maria, Calia, Rosaria, Di Vincenzo, Federica, Ferrajoli, Gaspare Filippo, Petito, Valentina, Maggio, Eleonora, Pafundi, Pia Clara, Napolitano, Daniele, Masi, Letizia, Schiavoni, Elisa, Fanali, Caterina, Puca, Pierluigi, Turchini, Laura, Lopetuso, Loris Riccardo, Del Chierico, Federica, Putignani, Lorenza, Gasbarrini, Antonio, Camardese, and Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628916/ https://www.ncbi.nlm.nih.gov/pubmed/37280117 http://dx.doi.org/10.1093/ibd/izad091

Ejemplares similares

Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis
por: Di Vincenzo, Federica, et al.
Publicado: (2022)

Bariatric procedures and microbiota: patient selection and outcome prediction
por: Puca, Pierluigi, et al.
Publicado: (2021)

Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Dietary Magnesium Alleviates Experimental Murine Colitis through Modulation of Gut Microbiota
por: Del Chierico, Federica, et al.
Publicado: (2021)

Commensal Clostridia: leading players in the maintenance of gut homeostasis
por: Lopetuso, Loris R, et al.
Publicado: (2013)

Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center
por: Pizzoferrato, Marco, et al.
Publicado: (2019)

Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis
por: Petito, Valentina, et al.
Publicado: (2019)

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

How to Face the Advent of SARS-CoV-2 Vaccination in IBD Patients: Another Task for Gastroenterologists
por: Papa, Alfredo, et al.
Publicado: (2021)

Gut Microbial Flora, Prebiotics, and Probiotics in IBD: Their Current Usage and Utility
por: Scaldaferri, Franco, et al.
Publicado: (2013)

Pre- and Posttherapy Assessment of Intestinal Soluble Mediators in IBD: Where We Stand and Future Perspectives
por: Scaldaferri, F., et al.
Publicado: (2013)

The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases
por: Baldelli, Valerio, et al.
Publicado: (2021)

Gut Microbiota Profiling and Gut–Brain Crosstalk in Children Affected by Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
por: Quagliariello, Andrea, et al.
Publicado: (2018)

Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients
por: Papa, Alfredo, et al.
Publicado: (2021)

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
por: Holleran, Grainne, et al.
Publicado: (2017)

Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study
por: Graziani, Cristina, et al.
Publicado: (2022)

Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19
por: Laterza, Lucrezia, et al.
Publicado: (2023)

Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide
por: Scaldaferri, F., et al.
Publicado: (2017)

Phylogenetic analysis of Prevotella copri from fecal and mucosal microbiota of IBS and IBD patients
por: Lo Presti, Alessandra, et al.
Publicado: (2023)

Nutrition, IBD and Gut Microbiota: A Review
por: Mentella, Maria Chiara, et al.
Publicado: (2020)

Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma
por: Ponziani, Francesca Romana, et al.
Publicado: (2022)

Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases?
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2019)

The Impact of Low-FODMAPs, Gluten-Free, and Ketogenic Diets on Gut Microbiota Modulation in Pathological Conditions
por: Reddel, Sofia, et al.
Publicado: (2019)

Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health
por: Vernocchi, Pamela, et al.
Publicado: (2016)

Gut Microbiota Metabolism and Interaction with Food Components
por: Vernocchi, Pamela, et al.
Publicado: (2020)

Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ianiro, Gianluca, et al.
Publicado: (2018)

Can We Predict the Efficacy of Anti-TNF-α Agents?
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2017)

Mediterranean Diet and Health: Food Effects on Gut Microbiota and Disease Control
por: Del Chierico, Federica, et al.
Publicado: (2014)

The Association of Disease Activity, BMI and Phase Angle with Vitamin D Deficiency in Patients with IBD
por: Mentella, Maria Chiara, et al.
Publicado: (2019)

Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Gut Microbiota Modulation for Multidrug-Resistant Organism Decolonization: Present and Future Perspectives
por: Gargiullo, Livia, et al.
Publicado: (2019)

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
por: Scaldaferri, Franco, et al.
Publicado: (2020)

Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies
por: Di Vincenzo, Federica, et al.
Publicado: (2023)

Orphan patients with inflammatory bowel disease - when we treat beyond evidence
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Infliximab does not increase colonic cancer risk associated to murine chronic colitis
por: Lopetuso, Loris R, et al.
Publicado: (2016)

Gut–Joint Axis: The Role of Physical Exercise on Gut Microbiota Modulation in Older People with Osteoarthritis
por: de Sire, Alessandro, et al.
Publicado: (2020)

Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis
por: Lopetuso, Loris R, et al.
Publicado: (2012)

Potential of multiomics technology in precision medicine
por: Putignani, Lorenza, et al.
Publicado: (2019)

A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics
por: Vernocchi, Pamela, et al.
Publicado: (2017)

The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kt60v0prs98lgv8i4tieonrm7p